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Neodymium: YAG Laser Therapy for
Palliative Treatment of Penile Kaposi's Sarcoma
Though laser therapy has had
long-standing success in
opthalmology and dermatology, its use in other fields is
just beginning. Recently, two
M. D. Anderson urologists,
Kenneth I. Wish now, M. D.,
and Douglas E. Johnson,
M. D., were the first to treat
penile Kaposi's sarcoma lesions
Kenneth I. Wishnow
with a neodymium:YAG
(yttrium, aluminum, garnet) laser.
' 'The neodymium:YAG laser has a lot of potential, especially in regard to the palliative treatment of patients with
AIDS (acquired immune deficiency syndrome) . The
patient we treated, like other AIDS patients, developed
Kaposi's sarcoma. Though we could not cure his systemic
disease, we successfully treated a local manifestation of it, "
said Wish now.
Like all lasers, the neodymium: YAG laser precisely delivers high energy to a discrete area, removing diseased tissue
while preserving normal tissue. But what distinguishes the
neodymium: YAG from most other lasers, Wish now said,
is its versatility. The neodymium: YAG laser, unlike the
more conventional CO 2 laser, has a wavelength suitable
for endoscopic use, and thus can be used to treat internal
tumors, such as those of the bladder. "It also has more tissue penetration and results in less bleeding," he said.
These advantages were important factors in deciding to
use the neodymium: YAG laser for this patient, Wish now
said. "We could have used a CO 2 laser, but since we didn't
know how deep the lesion was, we felt the better tissue
penetration of the neodymium: YAG laser would result in a
deeper surgical margin and therefore reduce the possibility

ofrecurrence. And because the penis is a very vascular
region, we were worried about bleeding. Though we could
have used it for the topical lesion, the CO 2 laser cannot
penetrate fluid as effectively. This makes it more difficult
to cauterize underlying blood vessels ."

The patient had a topical lesion on the glans penis adjacent to the urethral meatus, which was easily photoablated,
but the patient also had a second lesion in the fossa navicularis inside the urethra. To direct laser therapy to that lesion,
Wishnow and Johnson used a gastrointestinal optic fiber
passed through a panendoscope.
Though laser therapy was not the only possible form of
treatment for this lesion, it clearly was superior in terms of
morbidity, Wishnow said. "Radiation therapy might have
resulted in a deformity of the penis, and open surgery-a
total or partial penectomy-would have had a negative psychological impact on the patient. "
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Alternative Treatments Sometimes Necessary

Other Uses for Laser Therapy

Wishnow emphasized that such treatments are sometimes necessary, as in the case oflocal disease that has the
potential to metastasize. "If a potentially metastatic lesion
is locally curable, then initial treatment must be aggressive,
but in this case the patient had AIDS and thus a higher risk
of developing infection as a result of open surgery. Moreover, the penile lesion was a local manifestation of a systemic disease, so we could 'undertreat' the patient in the
sense that, if the lesion recurred, we could simply photoablate the lesion again."
The potential for metastasis was not a principal concern
in this case, but if the lesion had been a local carcinoma
with the potential to micrometastasize, then the patient's
survival would have hinged on complete eradication of the
disease. If this had been the case, then alternative treatments might have been necessary.
'' Because the neodymium: YAG laser had never been
used on a penile Kaposi's sarcoma lesion, we really didn ' t
know how likely the lesions were to return," Wishnow
said. However, to date, the lesions have not recurred in the
treated area, though other penile lesions have appeared in
untreated areas. If this form of therapy is as successful in
other patients, then the neodymium: YAG laser may play
an important role in palliative treatment for Kaposi's sarcoma, he said.

Laser therapy is currently available in many community
hospitals and can be used to treat noncancerous lesions as
well, according to Wish now. ''Lesions of the external genitalia, such as condyloma acuminatum, can very easily be
treated on an outpatient basis. "
Wishnow cautioned, however, that a confirmed diagnosis
is necessary before using laser therapy. "It is often necessary that a biopsy be performed so that histologic examination can confirm the diagnosis . If a lesion that is perceived
to be benign is destroyed when in fact it was a carcinoma,
you 're putting the patient at risk for metastasis. If you
eliminate the lesion before biopsy, obviously you're eliminating the only means of confirming the diagnosis."

Reduced Morbidity
In this case, a local manifestation of systemic disease had
compromised an organ's function. The Kaposi's sarcoma
lesion had made urination painful and difficult. 1reatment,
therefore, was directed at preserving the organ's function at
the least possible cost-both physically and psychologicallyto the patient, Wishnow said. "After treatment, the
patient reported no pain. Two or three days later he was
able to urinate well. One week later, the treated areas
showed tissue necrosis and minimal edema but no infection. The remarkable thing about laser therapy is that, even
though there seems to be a lot of destruction on the surface, actual penetration is only a few millimeters. Though
the epithelium is destroyed, the underlying tissue is preserved," Wishnow said.
Wishnow emphasized that in addition to reducing morbidity, the procedure is less expensive than other forms of
surgery. "This patient was treated as an outpatient. The
procedure was performed in less than an hour and the
patient went home the same day. Use of the laser is expensive, but this cost is more than offset by eliminating the
5- to 7-day hospitalization. This is significant, considering
that penile Kaposi's sarcoma, though once rare, is increasing in frequency as a result of AIDS."

Aside from ophthalmologic and dermatologic applications, which have become well established, laser therapy is
being explored for treating gynecologic, gastrointestinal,
cardiac, neurologic, thoracic, orthopedic, and head-andneck diseases, according to Wish now . '' If applications in
other fields have analogous results, then laser therapy, in
general, may ~nd up costing the patient less. The irony
of this treatment is that the laser itself is a very expensive
piece of equipment, but the decreased morbidity from
such treatment has other benefits, such as reducing-or
eliminating-the need for inpatient care. In my field,
whether laser therapy can effectively replace open surgery
remains to be seen, but in terms of palliative treatment for
local disease, its prospects are promising." ■

Physicians wh<;> desire additional information may write Kenneth I.
Wishnow, M .D., Department of Urology, Box 110, The University of
Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard,
Houston , Texas 77030, or call (7 13) 792-3250 .
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New Range of Fungal Infections Seen
in Cancer Patients

l

Species of the fungi Candida
and Asper;gillus sometimes
cause opportunistic fungal
infections in cancer patients.
Recently, however, severe
infections of this type were
traced to newly recognized
fungi such as Fusarium, Trichosporon, Bipolaris, Geotrichum
candidum, Cunninghamella,
Elias J. Anaissie
Curvularia, Pseudalescheria
boydii, and others, according to Elias J. Anaissie, M.D.,
assistant professor in the Section oflnfectious Diseases at
T he University ofTexas M. D. Anderson Cancer Center.
Patients who are profoundly neutropenic and remain so
fo r several weeks are most often affected-especially those
with hematologic malignancies such as acute myelogenous
leukemia and those receiving bone marrow transplants .
The main predisposing factors for the development of these
infections include bone marrow suppression, use ofbroadspectrum antibiotics, disruption of the integrity of the skin
and mucous membranes, and the use of immunosuppressive drugs. A few fungal infections have been related to the
use of central venous catheters.

not develop the classic signs and symptoms of infection
because of the lack of inflammatory response. The only
sign of infection may be a fever not responsive to adequate
and broad-spectrum antibiotics.''
Some of the isolates present as sinusitis, especially Fusarium, Bipolaris, and Curvularia; this suggests that the organisms are inhaled through the airways and " should alert us
to the possibility that sinus infection in the immunocompromised patient could be caused by one of these organisms, " he said.

Signs and Symptoms of Most Common Fungi
Most commonly encountered in recent experience are
Trichosporon beigelii and Fusarium species (see photographs).

Disseminated Trichosporon, nodular infarct with hyphae, arthroconidia, and a few yeasts .

Infections Difficult to Diagnose
Ranging from minor to life-threatening ones involving
multiple organs, these infections are usually disseminated,
especially in severely neutropenic patients.
" Unfortunately, the diagnosis of these infections may be
quite difficult," Anaissie said. "Neutropenic patients may

T beigelii is a saphrophytic organism often found on
the skin; it causes infection only if the host's defenses are
severely altered. Its clinical presentation is similar to that
continued on page 6
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Knowing How Normal Cells Differentiate Will Add
Rationality to Stopping Cancer Cells
By what biologic principles is
cancer connected to embryonic development?
William J. Lennarz, Ph.D.,
chairman of the Department
of Biochemistry and Molecular
Biology, speaks in questions
and answers, which are the
rhythm of his work, and he
makes clear quickly that those
William J. Lennorz
who study basic cancer mechanisms are a long way from understanding them.
He explained the connection between cellular development of the embryo and cancer by describing the cellular
process of the early stages oflife, the predifferentiated
stages during which identical cells replicate rapidly. During
differentiation, the next stage, cells begin to "differentiate
into specific subtypes," he said. "They become brain cells,
liver cells, and so on, and then their fate is sealed, their
schedule set. They can keep increasing-in the human
being until adolescence-and then begin a slow rate of
turnover but no longer rapid growth. But if cancer
develops, the cells return to a dedifferentiated stage of
rapid multiplication that eventually results in a tumor."

"We ask, " Lennarz said, " why and how does that cell
now lose its ability to maintain differentiation, its specific
characteristics? And the bottom line is that if you put my
back to the wall and ask me to describe the events, I can't
do it because I don't understand normal growth nor does
anybody else. Basically, then , we need to understand how
growth is controlled before we can answer the question,
What causes this cell to dedifferentiate and grow like crazy
to form a tumor?"

Sea Urchin a Useful Model
An accessible model for studying these basic processes is
the sea urchin embryo, Lennarz said, " because you can
produce these embryos in very large n umbers by mixing
sperm and eggs in the test tube; you can have millions
of them growing in synchrony-and perhaps even more
important, you can benefit by the knowledge of people
who have been studying the sea urchin embryo since the
discovery of the microscope. ' '

How Does a Cell Stop Differentiating?
What happens in cancer, he said, probably in several
steps, is that the differentiation program of a skin or kidney
or brain cell becomes perturbed, causing the cell to revert
to its primitive form, to dedifferentiate. It starts losing
some of its characteristic molecules.

One side of sea urchin embryo at 16-cell stage about five hours ofter fertilization.
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For hundreds of years, he said, "people have been peering at this organism, so we know which cell gives rise to
which tissue. And it's simpler and cheaper and everything
happens a lot faster than in the mammal. Some basic biologic processes, for instance the formation of the intestine
and the skeleton, have analogues in mammals, so this is a
reasonable model system" (see photographs).
In describing the process of differentiation, he said each
kind of cell in the body has a sort of "fingerprint collection
of molecules it makes." The liver cell produces serum
albumin to be pumped into the serum to carry lipids and
other components, and it produces transferrin, which picks
up iron to be returned to the cells. "So the liver cell has a
pattern of molecules it makes, controlled by a set of geneswhich are the same in all the cells of the whole organism,
but the genes turned on in the liver cell are different from
those in, say, the skin cell. " During this process the cell
involved in cancer reverts back to the earlier stage of rapid,
seemingly uncontrolled multiplication.
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Gostrula-stoge sea urchin embryo about 48 hours after fertilization, dry-fractured to
expose differentiating cells (arrow) that form the primitive gut. Cells inside wall at left
will form the skeleton . The embryo now consists of about 1000 cells .

Muscle to Mouse
Lennarz is the first chairman of his department, having
come here five years ago from Johns Hopkins University
School of Medicine where he was a professor in the department of biological chemistry. At the M. D. Anderson
Cancer Center, he is the Robert A. Welch professor of
chemistry. His department has 110 staff members, including 11 faculty members, 25 graduate students, and 35
postdoctoral trainees. All are engaged in studying one or
another aspect of cell differentiation because what Lennarz
calls the shotgun approach to cancer, to stopping abnormal
growth, will not be totally replaced by more rational methods until the riormal processes are known.
So, for example, Eric N. Olson, Ph.D., works on differentiation of muscle and other cells; Daniel D. Carson,
Ph.D., on how the mouse embryo becomes attached to

Flattened pluteus-stage embryo about 96 hours ofter fertilization , showing terminally
differentiated cells that form the skeleton.

continued on page 8
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Fungal Infections continued trom page 3
of disseminated candidiasis, which frequently causes metastatic skin lesions. These lesions may be diagnosed by
biopsy examination. "For diagnosis and therapy, it is useful to know that Trichsporon shares common antigenic
determinants with Cryptococcus neoformans. If you get a

,.,,.*_
ii>

V.

. t

~
''Several of the newly recognized fungi look.like Aspergillus or Candida in tissue. The only way to distinguish them
from commonly encountered fungi is to obtain a culture,"
he said . Culture specimens should be obtained from any
site of potential infection, including blood, sputum, urine,
and bone marrow, but blood culture will not yield the fu ngus in the majority of cases. Serum blood tests for detecting fungal antigens are currently being developed but are
not yet clinically applicable.

Acute branching septate hyphae of Fusarium in lungs.

Drug Resistance and Susceptibility
Cunninghamella, Trichosporon, and Pseudalescheria boydii
tend to resist amphotericin B, the drug most commonly
used to treat candidiasis and aspergillosis, making identification of the pathogen and establishment of drug sensitivity critical for the management of these patients.
Amphotericin B remains the treatment of choice unless
the offending organism has been shown to be resistant
to this drug and susceptible to other drugs or drug
combinations.
A new approach to preventing aspergillus pneumonitis
may be the use of aerosolized intranasal amphotericin B,
which has been shown in a limited series to prevent the
development of this life-threatening infection.

positive antigen for Cryptococcus in a cancer patient with
unexplained fever and without evidence of cryptococcal
infection, it is likely that the patient is infected with Trichosporon,'' said Anaissie.
Fusarium species, fungal organisms commonly present in
nature, were responsible in World War II for intoxicating
millions of people who ingested contaminated food. But
infections are rare and have been noted only recently, primarily in cancer patients. Fusarium tends to cause skin
lesions similar to those of aspergillus infections and, unlike
Aspergillus, Fusarium can be cultured from blood, Anaissie
explained.
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Use of the drug 5-flucytosine, in combination with
amphotericin B, has been advocated for treatment of disseminated candida infections, " but studies to support its
use are lacking," said Anaissie. Other possible drugs for
treating these fungal infections are miconazole and some
other newly described azoles such as itraconazole or fluconazole. But these drugs are fungistatic only and have not
been adequately studied in cancer patients.

ONCOLOG
President, The University of Texas M. D. Anderson Cancer Center
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Robin R. Sandefur, Ph.D.
Director, Deportment of Scientific Publications
Wolter J. Pagel

Neutrophil Count Most Important
" The patients' neutrophil count is the most important
factor in their recovery from fungal infections," said
Anaissie. "By using granulocyte-macrophage colonystimulating factor (GM-CSF), we try to shorten the duration of neutropenia in patients and thus either prevent or
treat some of these infections.''
In addition , said Anaissie, other newly developed antifungal drugs are u nder investigation for their potential as
prophylactic agents fo r fu ngal infections . ■
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Physicians who desire additional info rmation may write Elias J. Anaissie,
M .D. , Section of Infectious Diseases, Box 47, The University of Texas
M . D . Anderson Cancer Center, 1515 Ho lcombe Bouleva rd , Houston,
Texas 77030 , or call (7 13) 792-7303 .

Fall and Winter Conferences
Sponsored by The University of Texas M. D. Anderson Cancer Center

November 12, 1988
Update on Ovarian Cancer
M. D. Anderson Cancer Center

October 11-14, 1988
Forty-First Annual Symposium on Fundamental Cancer
Research
" Development and Differentiation: Modern Approaches
to Classical Problems"
Westin Galleria Hotel, Houston

January 12-14, 1989
First Annual Conference on Outpatient Ministry
"A.New Challenge in Pastoral Care"
M. D. Anderson Cancer Center

November 2-5, 1988
Thirty-Second Annual Clinical Conference
"Optimizing Management of Primary Bone Tumors:
An International Symposium Emphasizing the
Multi-Disciplinary Approach "
M. D. Anderson Cancer Center

For more information, write Office of Conference Services,
Box 131, The University ofTexas M. D. Anderson Cancer
Center, 1515 Holcombe Boulevard, Houston, Texas
77030, or call (713) 792-2222.
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Cell Differentiation continued trom page s
erate no more. It fuses with another cell, and they start
making a structure that we would eventually recognize as
muscle tissue. It's a program, and if the cell doesn ' t follow
that program, it may become a cancer cell."
Cell growth is the focus of much basic research around
the world, most of it unrelated to cancer, he said. "Some
cancer centers support research, some don ' t, and I think
our institution deserves credit for the fact that, in addition
to being known for the best possible cancer treatment, it
recognizes that the future of cancer treatment is in basic
research . ''
And since scientists are wishful thinkers by profession ,
Lennarz would like to believe, he said, that the principles
of growth control will be clarified in some great discovery,
and that this will open the door to a whole new way of
treating cancer. "No one has seen any direct sign of this
yet, " he said, "and anyway ifl saw it, I hope I would be
smart enough to make the discovery myself." ■

uterine epithelial cells and invades that tissue, a process
similar to cancer metastasis; and Barry D. Shur, Ph.D.,
on how cell surface molecules provide information to
the nucleus.
This last question, how cells know where they are, "is
becoming a fundamental issue," Lennarz said, "boiled
down to: cells know where they are in response to the environment because on the surface their binding molecules
interact with molecules on nearby cells, or with molecules
in the fluid around them . That binding process sends
molecular signals into the cells, which end up turning
genes on or off. A lot of the molecular details on how this
works are not totally clear, but that seems to be the general
strategy."

How Are Genes Reguh1ted?
The other theme of their work, perhaps broader and
overlapping, Lennarz said, is, "How are genes turned on
and off, how are they regulated~ Again, we're approaching
this using mainly normal, not cancer, cells. What are the
factors that cause a cell to become a muscle cell? That's a
terminal differentiation event; after that the cell will prolif-

Physicians who desire additional information may write William J.
Lennarz, Ph.D., Department of Biochemistry and Molecular Biology,
Box 117, The University ofTexas M. D. Anderson Cancer Center, 1515
Holcombe Boulevard, Houston, Texas 77030, or call (713) 792-8602 .

8

